{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:16:19Z","timestamp":1791850579445,"version":"4.3.4"},"reference-count":96,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Porphyrias Consortium","award":["U54DK083909"],"award-info":[{"award-number":["U54DK083909"]}]},{"name":"NCATS Rare Diseases Clinical Research Network"},{"DOI":"10.13039\/100007277","name":"Icahn School of Medicine at Mount Sinai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007277","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.ymgme.2018.12.008","type":"journal-article","created":{"date-parts":[[2018,12,27]],"date-time":"2018-12-27T12:50:17Z","timestamp":1545915017000},"page":"288-297","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"title":["Congenital erythropoietic porphyria: Recent advances"],"prefix":"10.1016","volume":"128","author":[{"given":"Angelika L.","family":"Erwin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Desnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2018.12.008_bb0005","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"2961","article-title":"Disorders of heme biosynthesis: X-linked sideroblastic anemia and the porphyrias","author":"Anderson","year":"2014"},{"key":"10.1016\/j.ymgme.2018.12.008_bb0010","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0140-6736(09)61925-5","article-title":"Porphyrias","volume":"375","author":"Puy","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2018.12.008_bb0015","doi-asserted-by":"crossref","first-page":"4496","DOI":"10.1182\/blood-2012-05-423186","article-title":"The porphyrias: advances in diagnosis and treatment","volume":"120","author":"Balwani","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2018.12.008_bb0020","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1073\/pnas.63.3.856","article-title":"Uroporphyrinogen 3 cosynthetase in human congenital erythropoietic porphyria","volume":"63","author":"Romeo","year":"1969","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0025","series-title":"Fitzpatrick's Dermatology in General Medicine","first-page":"1679","article-title":"The Porphyrias","author":"Bickers","year":"2012"},{"key":"10.1016\/j.ymgme.2018.12.008_bb0030","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1182\/blood-2006-06-022848","article-title":"Congenital erythropoietic porphyria due to a mutation in GATA1: the first trans-acting mutation causative for a human porphyria","volume":"109","author":"Phillips","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2018.12.008_bb0035","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/ejh.12452","article-title":"Congenital erythropoietic porphyria linked to GATA1-R216W mutation: challenges for diagnosis","volume":"94","author":"Di Pierro","year":"2015","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0040","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/bjh.13978","article-title":"Advances in understanding the pathogenesis of congenital erythropoietic porphyria","volume":"173","author":"Di Pierro","year":"2016","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0045","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1055\/s-2007-1007143","article-title":"Molecular genetics of congenital erythropoietic porphyria","volume":"18","author":"Desnick","year":"1998","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0050","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1046\/j.1365-2141.2002.03557.x","article-title":"Congenital erythropoietic porphyria: advances in pathogenesis and treatment","volume":"117","author":"Desnick","year":"2002","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0055","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.det.2014.03.001","article-title":"The cutaneous porphyrias","volume":"32","author":"Schulenburg-Brand","year":"2014","journal-title":"Dermatol. Clin."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0060","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/j.1365-2133.2012.11160.x","article-title":"Congenital erythropoietic porphyria: a single-observer clinical study of 29 cases","volume":"167","author":"Katugampola","year":"2012","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0065","series-title":"Congenital Erythropoietic Porphyria","author":"Erwin","year":"2013"},{"key":"10.1016\/j.ymgme.2018.12.008_bb0070","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1056\/NEJM198604173141607","article-title":"Complete suppression of the symptoms of congenital erythropoietic porphyria by long-term treatment with high-level transfusions","volume":"314","author":"Piomelli","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0075","first-page":"275","article-title":"The disruption of mouse uroporphyrinogen III synthase (uros) gene is fully lethal","volume":"2","author":"Bensidhoum","year":"1998","journal-title":"Transgenics"},{"key":"10.1016\/j.ymgme.2018.12.008_bb0080","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0738-081X(85)90034-3","article-title":"Porphyrin-sensitized cutaneous photosensitivity: pathogenesis and treatment","volume":"3","author":"Poh-Fitzpatrick","year":"1985","journal-title":"Clin. Dermatol."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0085","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF02110033","article-title":"Porphobilinogen deaminase and uroporphyrinogen III synthase: structure, molecular biology, and mechanism","volume":"27","author":"Shoolingin-Jordan","year":"1995","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0090","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0190-9622(97)70249-4","article-title":"Congenital erythropoietic porphyria","volume":"36","author":"Fritsch","year":"1997","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0095","first-page":"121","article-title":"Biochemical diagnosis of a fatal case of Gunther's disease in a newborn with hydrops foetalis","volume":"31","author":"Verstraeten","year":"1993","journal-title":"Eur. J. Clin. Chem. Clin. Biochem."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0100","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/geno.2000.6373","article-title":"Human uroporphyrinogen-III synthase: genomic organization, alternative promoters, and erythroid-specific expression","volume":"70","author":"Aizencang","year":"2000","journal-title":"Genomics"},{"key":"10.1016\/j.ymgme.2018.12.008_bb0105","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1074\/jbc.275.4.2295","article-title":"Uroporphyrinogen III synthase. An alternative promoter controls erythroid-specific expression in the murine gene","volume":"275","author":"Aizencang","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0110","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1172\/JCI10642","article-title":"Uroporphyrinogen III synthase erythroid promoter mutations in adjacent GATA1 and CP2 elements cause congenital erythropoietic porphyria","volume":"107","author":"Solis","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0115","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00439-017-1779-6","article-title":"The Human Gene Mutation Database: towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies","volume":"136","author":"Stenson","year":"2017","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0120","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1469-1809.1998.6230225.x","article-title":"C73R is a hotspot mutation in the uroporphyrinogen III synthase gene in congenital erythropoietic porphyria","volume":"62","author":"Frank","year":"1998","journal-title":"Ann. Hum. Genet."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0125","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF00278187","article-title":"The CpG dinucleotide and human genetic disease","volume":"78","author":"Cooper","year":"1988","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0130","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/B978-0-12-381262-9.00002-1","article-title":"Structural, thermodynamic, and mechanistical studies in uroporphyrinogen III synthase: molecular basis of congenital erythropoietic porphyria","volume":"83","author":"Fortian","year":"2011","journal-title":"Adv. Protein Chem. Struct. Biol."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0135","doi-asserted-by":"crossref","first-page":"5805","DOI":"10.1093\/hmg\/ddu298","article-title":"Tuning intracellular homeostasis of human uroporphyrinogen III synthase by enzyme engineering at a single hotspot of congenital erythropoietic porphyria","volume":"23","author":"Ben Bdira","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0140","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.0022-202X.2004.23401.x","article-title":"Congenital erythropoietic porphyria: report of a novel mutation with absence of clinical manifestations in a homozygous mutant sibling","volume":"123","author":"Ged","year":"2004","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0145","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1365-2133.2012.10954.x","article-title":"A puzzling mutation in congenital erythropoietic porphyria and an association with beta-thalassaemia trait","volume":"167","author":"Maakaron","year":"2012","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0150","doi-asserted-by":"crossref","first-page":"11598","DOI":"10.1073\/pnas.92.25.11598","article-title":"Alternative translation initiation site usage results in two functionally distinct forms of the GATA-1 transcription factor","volume":"92","author":"Calligaris","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0155","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/BF00201840","article-title":"Mapping the gene encoding the human erythroid transcriptional factor NFE1-GF1 to Xp11.23","volume":"86","author":"Caiulo","year":"1991","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0160","doi-asserted-by":"crossref","first-page":"28152","DOI":"10.1074\/jbc.M002053200","article-title":"GATA-1 bends DNA in a site-independent fashion","volume":"275","author":"Ghirlando","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0165","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1101\/gad.4.11.1886","article-title":"Transcriptional activation and DNA binding by the erythroid factor GF-1\/NF-E1\/Eryf 1","volume":"4","author":"Martin","year":"1990","journal-title":"Genes Dev."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0170","first-page":"4562","article-title":"Distinct roles for the two cGATA-1 finger domains","volume":"12","author":"Yang","year":"1992","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0175","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1182\/blood-2003-05-1556","article-title":"Recent insights into the mechanisms of myeloid leukemogenesis in Down syndrome","volume":"103","author":"Gurbuxani","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2018.12.008_bb0180","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1532\/IJH97.04180","article-title":"GATA transcription factors in hematologic disease","volume":"81","author":"Cantor","year":"2005","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0185","doi-asserted-by":"crossref","first-page":"5218","DOI":"10.1182\/blood-2013-03-488080","article-title":"Analysis of disease-causing GATA1 mutations in murine gene complementation systems","volume":"121","author":"Campbell","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2018.12.008_bb0190","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1172\/JCI115637","article-title":"Congenital erythropoietic porphyria: identification and expression of exonic mutations in the uroporphyrinogen III synthase gene","volume":"89","author":"Warner","year":"1992","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0195","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1038\/jid.2011.5","article-title":"Erythropoietic uroporphyria associated with myeloid malignancy is likely distinct from autosomal recessive congenital erythropoietic porphyria","volume":"131","author":"Sarkany","year":"2011","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0200","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1046\/j.1365-2133.2003.05040.x","article-title":"Congenital erythropoietic porphyria associated with myelodysplasia presenting in a 72-year-old man: report of a case and review of the literature","volume":"148","author":"Kontos","year":"2003","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0205","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1001\/archdermatol.2009.161","article-title":"Adult-onset erythropoietic porphyria in the setting of MDS","volume":"145","author":"Cernik","year":"2009","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0210","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1111\/bjd.14675","article-title":"Late-onset cutaneous porphyria in a patient heterozygous for a uroporphyrinogen III synthase gene mutation","volume":"175","author":"Aguilera","year":"2016","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0215","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0733-8635(18)30833-7","article-title":"The erythropoietic porphyrias","volume":"4","author":"Poh-Fitzpatrick","year":"1986","journal-title":"Dermatol. Clin."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0220","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/ced.12932","article-title":"Congenital erythropoietic porphyria: mild presentation with late onset associated with a mutation in the UROS gene promoter sequence","volume":"41","author":"Fityan","year":"2016","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0225","first-page":"551","article-title":"Congenital erythropoietic porphyria (Gunther's disease): enzymatic studies on two cases of late onset","volume":"97","author":"Deybach","year":"1981","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0230","first-page":"357P","article-title":"Adult-onset congenital erythropoietic porphyria (Gunther's disease) presenting with thrombocytopenia","volume":"88","author":"Murphy","year":"1995","journal-title":"J. R. Soc. Med."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0235","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1136\/bmj.3.5984.621","article-title":"Erythropoietic uroporphyria of Gunther first presenting at 58\u202fyears with positive family studies","volume":"3","author":"Pain","year":"1975","journal-title":"Br. Med. J."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0240","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/j.1365-2141.1965.tb00115.x","article-title":"The anemia of erythropoietic prophyria with the description of the disease in an elderly patient","volume":"11","author":"Kramer","year":"1965","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0245","first-page":"564","article-title":"Late onset erythropoietic porphyria (Gunther's disease)","volume":"21","author":"Rao","year":"2011","journal-title":"J. Coll. Physicians Surg. Pak."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0250","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1159\/000029857","article-title":"Congenital erythropoietic porphyria","volume":"11","author":"Fritsch","year":"1998","journal-title":"Skin Pharmacol. Appl. Ski. Physiol."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0255","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1182\/blood.V10.5.416.416","article-title":"Erythropoietic (congenital) porphyria: A rare abnormality of the normoblasts","volume":"10","author":"Schmid","year":"1955","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2018.12.008_bb0260","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/0020-711X(78)90071-X","article-title":"Congenital erythropoietic uroporphyria (Gunther's disease) presenting in a middle aged man","volume":"9","author":"Weston","year":"1978","journal-title":"Int. J. BioChemiPhysics"},{"key":"10.1016\/j.ymgme.2018.12.008_bb0265","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1046\/j.1442-9071.2000.00330.x","article-title":"Congenital porphyria with necrotizing scleritis in a 9-year-old child","volume":"28","author":"Venkatesh","year":"2000","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0270","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/ICO.0b013e3181e458fa","article-title":"Scleral necrosis in a patient with congenital erythropoietic porphyria","volume":"30","author":"Siddique","year":"2011","journal-title":"Cornea"},{"key":"10.1016\/j.ymgme.2018.12.008_bb0275","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/BF01955245","article-title":"Ocular involvement in two symptomatic congenital erythropoietic porphyria","volume":"152","author":"Oguz","year":"1993","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0280","first-page":"307","article-title":"Severe osteopenia in congenital erythropoietic porphyria","volume":"45","author":"Laorr","year":"1994","journal-title":"Can. Assoc. Radiol. J."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0285","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s100240010143","article-title":"Congenital erythropoietic porphyria: prenatal diagnosis and autopsy findings in two sibling fetuses","volume":"4","author":"Daikha-Dahmane","year":"2001","journal-title":"Pediatr. Dev. Pathol."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0290","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1001\/archderm.1992.01680190099013","article-title":"Congenital erythropoietic porphyria. A mild variant with low uroporphyrin I levels due to a missense mutation (A66V) encoding residual uroporphyrinogen III synthase activity","volume":"128","author":"Warner","year":"1992","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0295","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/(SICI)1096-8628(19970613)70:3<299::AID-AJMG16>3.0.CO;2-G","article-title":"Novel point mutation in the uroporphyrinogen III synthase gene causes congenital erythropoietic porphyria of a Japanese family","volume":"70","author":"Takamura","year":"1997","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0300","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1046\/j.1365-2141.2002.03558.x","article-title":"Congenital erythropoietic porphyria: identification and expression of eight novel mutations in the uroporphyrinogen III synthase gene","volume":"117","author":"Shady","year":"2002","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0305","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1182\/blood.V92.11.4053","article-title":"Congenital erythropoietic porphyria successfully treated by allogeneic bone marrow transplantation","volume":"92","author":"Tezcan","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2018.12.008_bb0310","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1172\/JCI117742","article-title":"Congenital erythropoietic porphyria: identification and expression of 10 mutations in the uroporphyrinogen III synthase gene","volume":"95","author":"Xu","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0315","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1159\/000472214","article-title":"A systematic analysis of the mutations of the uroporphyrinogen III synthase gene in congenital erythropoietic porphyria","volume":"4","author":"Fontanellas","year":"1996","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0320","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/BF02281859","article-title":"A novel point mutation in congenital erythropoietic porphyria in two members of Japanese family","volume":"97","author":"Tanigawa","year":"1996","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0325","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/BF00197267","article-title":"Heterogeneity of mutations in the uroporphyrinogen III synthase gene in congenital erythropoietic porphyria","volume":"88","author":"Boulechfar","year":"1992","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0330","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ajhg.2008.08.003","article-title":"C-terminal deletions in the ALAS2 gene lead to gain of function and cause X-linked dominant protoporphyria without anemia or iron overload","volume":"83","author":"Whatley","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0335","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2119\/molmed.2012.00340","volume":"19","author":"Balwani","year":"2013","journal-title":"Mol. Med."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0340","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2119\/molmed.2013.00003","article-title":"Molecular expression and characterization of erythroid-specific 5-aminolevulinate synthase gain-of-function mutations causing X-linked protoporphyria","volume":"19","author":"Bishop","year":"2013","journal-title":"Mol. Med."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0345","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1182\/blood-2011-03-342873","article-title":"ALAS2 acts as a modifier gene in patients with congenital erythropoietic porphyria","volume":"118","author":"J. To-Figueras","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2018.12.008_bb0350","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0022-3476(96)70082-3","article-title":"Correction of congenital erythropoietic porphyria by bone marrow transplantation","volume":"129","author":"Thomas","year":"1996","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0355","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1067\/mjd.2001.114730","article-title":"Treatment of severe congenital erythropoietic porphyria by bone marrow transplantation","volume":"45","author":"Harada","year":"2001","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0360","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/sj.bmt.1702738","article-title":"Treatment of congenital erythropoietic porphyria in children by allogeneic stem cell transplantation: a case report and review of the literature","volume":"27","author":"Shaw","year":"2001","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0365","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s00431-004-1575-x","article-title":"Successful match-unrelated donor bone marrow transplantation for congenital erythropoietic porphyria (Gunther disease)","volume":"164","author":"Dupuis-Girod","year":"2005","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0370","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1365-2133.2006.07699.x","article-title":"Allogeneic bone marrow transplantation in a 7-year-old girl with congenital erythropoietic porphyria: a treatment dilemma","volume":"156","author":"Taibjee","year":"2007","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0375","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1399-3046.2007.00842.x","article-title":"Unrelated HSCT in an adolescent affected by congenital erythropoietic porphyria","volume":"12","author":"Faraci","year":"2008","journal-title":"Pediatr. Transplant."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0380","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/j.1365-2133.2012.11154.x","article-title":"A management algorithm for congenital erythropoietic porphyria derived from a study of 29 cases","volume":"167","author":"Katugampola","year":"2012","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0385","first-page":"217","article-title":"Successful cord blood stem cell transplantation for congenital erythropoietic porphyria (Gunther's disease)","volume":"18","author":"Zix-Kieffer","year":"1996","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0390","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/0140-6736(91)93198-I","article-title":"Bone-marrow transplantation for congenital erythropoietic porphyria","volume":"337","author":"Kauffman","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2018.12.008_bb0395","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1749-6632.1993.tb26164.x","article-title":"Carotenoids in erythropoietic protoporphyria and other photosensitivity diseases","volume":"691","author":"Mathews-Roth","year":"1993","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0400","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/ajd.12451","article-title":"Beneficial use of a novel topical hypochlorous acid preparation for chronic dematoses at risk of secondary infection","volume":"57","author":"Howard","year":"2016","journal-title":"Australas. J. Dermatol."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0405","series-title":"Erythropoietic Protoporphyria, Autosomal Recessive","author":"Balwani","year":"1993"},{"key":"10.1016\/j.ymgme.2018.12.008_bb0410","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1742-1241.2002.tb11255.x","article-title":"Management of acute and cutaneous porphyrias","volume":"56","author":"Badminton","year":"2002","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0415","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1056\/NEJMoa1411481","article-title":"Afamelanotide for erythropoietic protoporphyria","volume":"373","author":"Langendonk","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0420","doi-asserted-by":"crossref","DOI":"10.5070\/D3232033965","article-title":"Congenital erythropoietic porphyria (Gunther disease) - long-term follow up of a case and review","volume":"23","author":"Howard","year":"2017","journal-title":"Dermatol. Online J."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0425","series-title":"Dermatology in Five Continents","article-title":"Congenital erythropoietic porphyria: complete suppression of symptoms by long-term high-level transfusion with deferoxamine infusion iron rescue","author":"Poh-Fitzpatrick","year":"1988"},{"key":"10.1016\/j.ymgme.2018.12.008_bb0430","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1056\/NEJM199404143301519","article-title":"Hydroxyurea in congenital erythropoietic porphyria","volume":"330","author":"Guarini","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0435","first-page":"645","article-title":"Rapid improvement in the chemical pathology of congenital erythropoietic porphyria with treatment with superactivated charcoal","volume":"12","author":"Tishler","year":"1990","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0440","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJM199404143301520","article-title":"Lack of effect of oral charcoal in congenital erythropoietic porphyria","volume":"330","author":"Minder","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0445","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/(SICI)1099-0801(199811\/12)12:6<350::AID-BMC761>3.0.CO;2-B","article-title":"Porphyrins in urine, plasma, erythrocytes, bile and feces in a case of congenital erythropoietic porphyria (Gunther's disease) treated with blood transfusion and iron chelation: lack of benefit from oral charcoal","volume":"12","author":"Gorchein","year":"1998","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0450","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1182\/blood-2014-07-584664","article-title":"Inducing iron deficiency improves erythropoiesis and photosensitivity in congenital erythropoietic porphyria","volume":"126","author":"Egan","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2018.12.008_bb0455","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ajhg.2007.09.007","article-title":"Effective gene therapy of mice with congenital erythropoietic porphyria is facilitated by a survival advantage of corrected erythroid cells","volume":"82","author":"Robert-Richard","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0460","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ajhg.2012.05.026","article-title":"Metabolic correction of congenital erythropoietic porphyria with iPSCs free of reprogramming factors","volume":"91","author":"Bedel","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0465","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1093\/hmg\/ddx067","article-title":"Missense UROS mutations causing congenital erythropoietic porphyria reduce UROS homeostasis that can be rescued by proteasome inhibition","volume":"26","author":"Blouin","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0470","doi-asserted-by":"crossref","first-page":"18238","DOI":"10.1073\/pnas.1314177110","article-title":"Therapeutic potential of proteasome inhibitors in congenital erythropoietic porphyria","volume":"110","author":"Blouin","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2018.12.008_bb0475","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.anpedi.2014.01.005","article-title":"Wood's lamp in congenital erythropoietic porphyria","volume":"81","author":"Blasco Morente","year":"2014","journal-title":"An Pediatr. (Barc)"},{"key":"10.1016\/j.ymgme.2018.12.008_bb0480","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4103\/0973-029X.80022","article-title":"Erythrodontia in congenital erythropoietic porphyria","volume":"15","author":"Bhavasar","year":"2011","journal-title":"J. Oral Maxillofac. Pathol."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719218306474?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719218306474?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:24:56Z","timestamp":1761089096000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719218306474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":96,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S1096719218306474"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2018.12.008","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Congenital erythropoietic porphyria: Recent advances","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2018.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}